Multi-modality imaging provides essential diagnostic tools for the etiologic work-up of new heart failure with reduced ejection fraction, aiding in narrowing the differential diagnosis.
This review highlights the importance of multimodality imaging in determining the underlying etiology of HFrEF to guide specific therapies.
Heart failure with reduced ejection fraction (HFrEF) is a common reason for referral to cardiology for etiologic work-up and management. Although guideline-directed medical therapies (GDMT) are recommended for all HFrEF patients, some may also benefit from specific therapies directed at the underlying cardiac pathology. Advances in cardiac imaging provide the contemporary cardiologist with multiple diagnostic tools and understanding their utility in the workup of HFrEF is essential to high quality patient care. We provide an overview on the role of multi-modality imaging for the etiologic work-up of new HFrEF, as well as a suggested algorithm to narrow the differential diagnosis.
Sarwar et al. (Sun,) conducted a review in Heart failure with reduced ejection fraction (HFrEF). Multi-modality imaging was evaluated. Multi-modality imaging provides essential diagnostic tools for the etiologic work-up of new heart failure with reduced ejection fraction, aiding in narrowing the differential diagnosis.